These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2035107)

  • 1. Alzheimer's disease.
    Harrell LE
    South Med J; 1991 May; 84(5 Suppl 1):S32-40. PubMed ID: 2035107
    [No Abstract]   [Full Text] [Related]  

  • 2. The neural correlates of verbal short-term memory in Alzheimer's disease: an fMRI study.
    Peters F; Collette F; Degueldre C; Sterpenich V; Majerus S; Salmon E
    Brain; 2009 Jul; 132(Pt 7):1833-46. PubMed ID: 19433442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral abnormalities in Alzheimer's disease.
    Robert PH; Médecin I
    Ann Med Interne (Paris); 1998 Jun; 149(4):216-20. PubMed ID: 11490549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's unease.
    Hensrud DD
    Fortune; 2002 Oct; 146(8):226. PubMed ID: 12407786
    [No Abstract]   [Full Text] [Related]  

  • 6. Memory testing to improve the differential diagnosis of Alzheimer's disease.
    Albert MS; Moss MB; Milberg W
    Prog Clin Biol Res; 1989; 317():55-69. PubMed ID: 2690114
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease.
    Cummings JL; Masterman DL
    J Clin Psychiatry; 1998; 59 Suppl 13():23-30. PubMed ID: 9771827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences of general practitioners and carers of Alzheimer patients regarding the use of neuroleptics for behavioural disorders in Alzheimer's disease.
    Gonzalez-Moneo MJ; Simó M; Pie M; Rivero D
    Int J Geriatr Psychiatry; 2008 Oct; 23(10):1095-7. PubMed ID: 18613282
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical antipsychotic drugs and Alzheimer's disease.
    Jockers-Scherübl MC; Hellweg R
    N Engl J Med; 2007 Jan; 356(4):416-7; author reply 417-8. PubMed ID: 17256186
    [No Abstract]   [Full Text] [Related]  

  • 10. Alzheimer's disease. Short precursor shortens memory.
    Mattson MP; Furukawa K
    Nature; 1997 May; 387(6632):457-8. PubMed ID: 9168104
    [No Abstract]   [Full Text] [Related]  

  • 11. Alzheimer's disease management.
    Rabins PV
    J Clin Psychiatry; 1998; 59 Suppl 13():36-8. PubMed ID: 9771829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mnemonic anosognosia in Alzheimer's disease: a test of Agnew and Morris (1998).
    Ansell EL; Bucks RS
    Neuropsychologia; 2006; 44(7):1095-102. PubMed ID: 16324727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
    Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
    J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A very long goodbye. The ravages of Alzheimer's disease.
    Goldberg B
    ASHA; 1996; 38(4):24-6, 28-9, 31. PubMed ID: 8917940
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical aspects and course of Alzheimer's disease].
    Poncet M; Guinot H
    Rev Prat; 1989 Feb; 39(6):462-5. PubMed ID: 2704959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential therapeutic targets in the NF-kappaB pathway for Alzheimer's disease.
    Collister KA; Albensi BC
    Drug News Perspect; 2005 Dec; 18(10):623-9. PubMed ID: 16491164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Care of individuals with Alzheimer's disease in the new millennium.
    Souder E; Rapp CG; Davis GV; Beck C; Liem PH
    Medsurg Nurs; 2004 Feb; 13(1):22-31. PubMed ID: 15029928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intact haptic priming in normal aging and Alzheimer's disease: evidence for dissociable memory systems.
    Ballesteros S; Reales JM
    Neuropsychologia; 2004; 42(8):1063-70. PubMed ID: 15093145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen replacement therapy: effects on the cognitive functioning and clinical course of women with Alzheimer's disease.
    Levine AJ; Battista M
    Arch Clin Neuropsychol; 2004 Sep; 19(6):769-78. PubMed ID: 15288330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.